The heart is better protected against myocardial infarction in the fed state compared to the fasted state-Reference-Cited by-同舟云学术

The heart is better protected against myocardial infarction in the fed state compared to the fasted state

Published:2014-01 Issue:1 Volume:63 Page:127-136
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Liepinsh Edgars,Makrecka Marina,Kuka Janis,Makarova Elina,Vilskersts Reinis,Cirule Helena,Sevostjanovs Eduards,Grinberga Solveiga,Pugovics Osvalds,Dambrova Maija

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference49 articles.

1. Adipose tissue: friend or foe?;Hassan;Nat Rev Cardiol,2012

2. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss;Lavie;J Am Coll Cardiol,2009

3. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet;Klempel;Metabolism,2013

4. Effects of a single bout of aerobic exercise on short-term low-carbohydrate/high-fat intake-induced postprandial glucose metabolism during an oral glucose tolerance test;Numao;Metabolism,2013

5. Hypoglycemia, diabetes, and cardiovascular events;Desouza;Diabetes Care,2010

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Considerations in Direct Procurement and Perfusion Protocols with DCD Heart Transplantation;International Journal of Molecular Sciences;2024-04-09

2. Heart-Type Fatty Acid Binding Protein Binds Long-Chain Acylcarnitines and Protects against Lipotoxicity;International Journal of Molecular Sciences;2023-03-14

3. Fasting increases susceptibility to acute myocardial ischaemia/reperfusion injury through a sirtuin-3 mediated increase in fatty acid oxidation;Scientific Reports;2022-11-29

4. Cardioprotective Effects of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis;Seminars in Thoracic and Cardiovascular Surgery;2022-11

5. Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials;Pharmacological Reviews;2022-06-16